United Kingdom· GB-APID-32965811000001108
Uptravi 1,200microgram tablets
A medicinal product containing selexipag, registered in United Kingdom by Janssen-Cilag Ltd.
Checked against NHS dm+d (United Kingdom) on
Informational only — not a medical device.
The record
At a glance
NHS dm+d (United Kingdom)- Active substance
- Selexipag
- Manufacturer
- Janssen-Cilag Ltd
- Country
- United Kingdom (GB)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- NHS dm+d (United Kingdom)
- Last checked
- September 13, 2026
Packs & prices · 2
- gtin7640111931935
- gtin7640111934264
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Selexipag in 15 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CanadaUPTRAVIJANSSEN INC
- NetherlandsSelexipag Abdi 1.000 microgram filmomhulde tablettenAbdi Farma GmbH
- SwedenSelexipag Accord 1000 mikrogram Filmdragerad tablettAccord Healthcare B.V.
- CzechiaSELEXIPAG ACCORDACCORD HEALTHCARE POLSKA Sp. z o.o., Varšava
- PolandSelexipag AccordAccord Healthcare Polska Sp. z o.o.
- SpainSELEXIPAG ACCORD 1000 MICROGRAMOS COMPRIMIDOS RECUBIERTOS CON PELICULA EFGAccord Healthcare S.L.U.
- United StatesSelexipagZydus Lifesciences Limited
- IrelandSelexipag Accord 1 000 microgram film-coated tabletsAccord Healthcare Ireland Ltd.
Authorised across Europe · EMA
The same active substance is authorised in 19 EEA countries. Names it is sold under:
- Austria · Selexipag Ratiopharm
- Cyprus · Selexipag Accord
- Denmark · Selexipag Accord, Selexipag Stada
- Estonia · Selexipag Stada
- Spain · Selexipag Accord, Selexipag Stada
- Greece · Xipeno
- Croatia · Seleksipag Accord
- Ireland · Selexipag Accord, Selexipag Clonmel
- Iceland · Selexipag Stada, Uptravi
- Italy · Selexipag Accord, Selexipag Eg
- Liechtenstein · Uptravi
- Lithuania · Selexipag Stada
- Latvia · Selexipag Stada
- Malta · Selexipag Clonmel
- Netherlands · Seleksipag Accord, Selexipag Abdi
- Norway · Selexipag Accord, Selexipag Stada
- Poland · Selexipag, Selexipag Accord
- Portugal · Selexipag Accord, Selexipag Teva
- Sweden · Selexipag, Selexipag Accord
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of NHS dm+d (United Kingdom). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/dd581fa6-4432-452c-8972-2a9f9dee95db GET /v1/drugs/dd581fa6-4432-452c-8972-2a9f9dee95db?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"apid": "32965811000001108",
"desc": "Uptravi 1,200microgram tablets (Janssen-Cilag Ltd)",
"form": "Oral tablet",
"vpid": "32965611000001109",
"source": "dmd",
"vtm_id": "781378002",
"strength": "1.2 mg",
"substance": "Selexipag",
"ingredient": "Selexipag",
"supplier_code": "2422501000001106"
}See everything about selexipag.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.